Efficacy of serotonin receptor blocker for symptomatic lumbar disc herniation

Clinical Orthopaedics and Related Research

Volumn 411, Issue , 2003, Pages 159-165

  Kanayama, Masahiro ^a   Hashimoto, Tomoyuki ^b   Shigenobu, Keiichi ^b   Yamane, Shigeru ^b  

^a HAKODATE CENTRAL GENERAL HOSPITAL   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; METHYSERGIDE; METHYSERGIDE MALEATE; NONSTEROID ANTIINFLAMMATORY AGENT; SARPOGRELATE; SEROTONIN; SEROTONIN 2A ANTAGONIST; SEROTONIN ANTAGONIST;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; HUMAN; INFLAMMATION; INTERVERTEBRAL DISK HERNIA; ISCHIALGIA; LOW BACK PAIN; LUMBAR DISK HERNIA; MALE; NERVE ROOT; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEUS PULPOSUS; PRIORITY JOURNAL; SCIATIC NERVE; SEROTONIN BLOOD LEVEL; SYMPTOMATOLOGY; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

EID: 0037566316     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/01.blo.0000065840.77325.8f     Document Type: Article

References (25)

1. Cohen MS, Wall EJ, Brown RA, Rydevik B, Garfin SR: Cauda equina anatomy: II. Extrathecal nerve roots and dorsal root ganglia. Spine 15:1248-1251, 1990.
2. Cooper RG, Freemont AJ, Hoyland JA, et al: Hemiated intervertebral disc-associated periradicular fibrosis and vascular abnormalities occur without inflammatory cell infiltration. Spine 20:591-598, 1995.
3. Cornefjord M, Olmarker K, Farley DB, Weinstein JN, Rydevik B: Neuropeptide changes in compressed spinal nerve roots. Spine 20:670-673, 1995.
4. 2A receptors. Neurosci Res 29:143-149, 1997.
5. 3 receptor antagonist reduce c-fos expression in the trigeminal nuclear complex following noxious chemical stimulation of the rat nasal mucosa. Brain Res 676:336-342, 1995.
6. Engbaek F, Voldby B: Radioimmunoassay of serotonin (5-hydroxytryptamine) in cerebrospinal fluid, plasma, and serum. Clin Chem 28:624-628, 1982.
7. 3 receptor antagonists in the mouse. Neuropharmacology 28:423-427, 1989.
8. 3 receptor antagonists reduce inflammatory pain in the rat. Eur J Pharmacol 170:83-86, 1989.
9. 3 receptor antagonist. Neurosci Lett 95:313-317, 1988.
10. 2A receptor antagonist sarpogrelate in diabetic patients with complications. Clin Drug Invest 18:199-207, 1999.
11. Hoyer D, Clerke DE, Fozard JR, et al: International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 46:157-203, 1994.
12. McCarron RF, Wimpee MW, Hudkins P, Laros GS: The inflammatory effect of nucleus pulposus: A possible element in the pathogenesis of low-back pain. Spine 12:760-764, 1987.
13. Mense S: Pathophysiology of low back pain and the transition to the chronic state: Experimental data and new concepts. Schmerz 15:413-417, 2001.
14. 2A receptor activation in inflammatory pain. Nippon Rinsho 59:1675-80, 2001.
15. Olmarker K, Blomquist J, Stromberg J, et al: Inflammatogenic properties of nucleus pulposus. Spine 20:665-669, 1995.
16. Olmarker K, Rydevik B, Nordborg C: Autologous nucleus pulposus induces neurophysiologic and histologic changes in porcine cauda equina nerve roots. Spine 18:1425-1432, 1993.
17. Page CP: Platelets as inflammatory cells. Immunopharmacology 17:51-59, 1989.
18. Pakszys W, Holyst M, Rymkiewicz T: Clinical and biochemical studies on the administration of preparation UML-491 (Deseril), a serotonin antagonist, in the treatment of sciatica caused by herniation of intervertebral disk. Neurol Neurochir Pol 3:19-24, 1969.
19. Richardson BP, Engel G, Donatsch P, Stadler PA: Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs. Nature 316:126-131, 1985.
20. Rydevik B, Brown MD, Ehira T, Nordborg C: Effects of graded compression and nucleus pulposus on nerve tissue: An experimental study in rabbits. Acta Orthop Scand 54:670-671, 1983.
21. Saal JS, Franson RC, Dobrow R, et al: High levels of inflammatory phospholipase A2 activity in lumbar disc herniations. Spine 15:674-678, 1990.
22. Schmeiz M, Osiander G, Blunk J, et al: Intracutaneous injections of platelets causes acute pain and protracted hyperalgesia. Neurosci Lett 226:171-174, 1997.
23. Taiwo YO, Levine JD: Serotonin is a directly-acting hyperalgesic agent in the rat. Neuroscience 48:485-490, 1992.
24. 2A receptor subtype is involved in the thermal hyperalgesic mechanism of serotonin in the periphery. Pain 76:349-355, 1998.
25. Villalon CM, Terron JA, Ramirez-San Juan E, Saxena PR: 5-hydroxy-tryptamine: Considerations about discovery, receptor classification and relevance to medical research. Arch Med Res 26:331-344, 1995.